E3 ubiquitin ligase nedd4 affects estrogen receptor expression and the prognosis of patients with hormone receptor-positive breast cancer

HIGHLIGHTS

• who: Yutaka Natori and collaborators from the Department of Medical Oncology, Fukushima Medical University, Fukushima, Japan have published the research work: E3 Ubiquitin Ligase NEDD4 Affects Estrogen Receptor Expression and the Prognosis of Patients with Hormone Receptor-Positive Breast Cancer, in the Journal: Cancers 2022, 14, x FOR PEER REVIEW of 10/Nov/2020
• what: This study is the first to demonstrate that NEDD4 affects the expression of ERu03b1 and influences the prognosis of breast cancer patients.
• how: The authors employed clinical and biological approaches to elucidate the prognostic impact of NEDD4 on . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.